Overcoming MET-dependent resistance to selective RET inhibition in patients with RET fusion⇓positive lung cancer by combining selpercatinib with crizotinib

Ezra Y. Rosen, Melissa L. Johnson, Sarah E. Clifford, Romel Somwar, Jennifer F. Kherani, Jieun Son, Arrien A. Bertram, Monika A. Davare, Eric Gladstone, Elena V. Ivanova, Dahlia N. Henry, Elaine M. Kelley, Mika Lin, Marina S.D. Milan, Binoj C. Nair, Elizabeth A. Olek, Jenna E. Scanlon, Morana Vojnic, Kevin Ebata, Jaclyn F. HechtmanBob T. Li, Lynette M. Sholl, Barry S. Taylor, Marc Ladanyi, Pasi A. Janne, S. Michael Rothenberg, Alexander Drilon, Geoffrey R. Oxnard

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Overcoming MET-dependent resistance to selective RET inhibition in patients with RET fusion⇓positive lung cancer by combining selpercatinib with crizotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences